Nicholas Jacobus

Eli Lilly partners with the Indiana Fever and YMCA to empower girls in basketball, removing barriers and promoting community engagement in sports.

Connect Biopharma partners with the Jovante Woods Foundation to enhance asthma education and awareness, aiming to prevent acute attacks and save lives.

Seal Rock Therapeutics joins The Michael J. Fox Foundation's LITE program to help advance research and developments in inhibitors targeting LRRK2 in Parkinsons disease.

Oikos Fusion offers a nutrient-dense dairy drink designed to support muscle mass and digestive health during weight loss journeys.

Monica Seles partners with argenx to raise awareness for Myasthenia Gravis, sharing her journey to empower and support those affected by the condition.

Bayer partners with Kumquat Biosciences to advance a promising Kras G12D cancer treatment, aiming to address critical unmet medical needs in oncology.

Vor Bio appoints Dallan Murray as chief commercial officer, leveraging his extensive experience to drive commercialization and growth strategies for innovative therapies.

A new CDC campaign "Free Mind" addresses rising drug overdoses and mental health issues among youth, offering vital resources for teens and caregivers.

GLP-1 medication users must consult physicians before surgery to mitigate anesthesia risks and ensure safe pre-operative practices.

Radella Pharmaceuticals reveals promising Phase 1b trial results for MD-18, showcasing significant weight loss and cardiometabolic health improvements.

Chai Discovery secures $70 million to revolutionize AI-driven drug discovery, enhancing antibody design and accelerating breakthroughs in medicine.

XtalPi and DoveTree collaborate on a groundbreaking $6 billion drug discovery partnership, merging AI technology with biological expertise to tackle complex diseases.

Currax Pharmaceuticals expands its impactful campaigns, showcasing real patient stories to empower those battling obesity and food cravings across the U.S.

Celltrion's Avtozma IV gains FDA approval for treating cytokine release syndrome, enhancing treatment options for patients aged 2 and older.

Explore how Wounded Warrior Project and advocates like Morgan Fox promote mental health awareness and support for veterans facing PTSD and depression.

The choice reflects the company's aims to revolutionize chronic care and expand global health solutions through innovative technology.

Sanofi secures exclusive rights to develop plozasiran in Greater China, enhancing treatment options for hypertriglyceridemia and expanding its cardiometabolic portfolio.

LENZ Therapeutics celebrates FDA approval of Vizz, the first aceclidine eye drop for presbyopia.

FDA mandates new opioid labeling to highlight long-term risks, aiming to combat addiction and improve patient safety in pain management.

Eli Lilly's Mounjaro shows significant cardiovascular benefits in a major trial enhancing treatment options for type 2 diabetes patients.

Viridian Therapeutics partners with Kissei Pharmaceutical to advance treatments for thyroid eye disease in Japan, enhancing patient care and market potential.

Aetna enhances user experience with AI-driven Care Paths, simplifying health navigation and personalizing care for members and providers alike.

Madrigal Pharmaceuticals secures global rights to SYH2086, aiming to enhance MASH treatment with innovative combination therapies for better patient outcomes.

The survey reveals how financial anxiety has become an everyday occurrence affecting everyday health through stress, relationship strain, and lack of sleep.

GSK sponsors the 2025 National Senior Games to raise awareness about RSV risks and prevention for older adults through education and athlete stories.

Current Novo Nordisk executive vice president of internal operations is named new president and CEO.

Boehringer Ingelheim partners with Re-Vana Therapeutics to innovate long-acting eye disease treatments, enhancing patient care and compliance.

Hengrui Pharma partners with GSK to develop 12 innovative medicines, enhancing COPD treatment and expanding global growth opportunities.

The segment will provide education and support strategies.

Eli Lilly's acquisition of Vere Therapeutics promises to revolutionize cardiovascular care with innovative one-time gene editing treatments for high-risk patients.